Is HUMA stock safe? | Glauxie AI

Q: Is HUMA stock safe?

Humacyte, Inc. (HUMA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Laura E. Niklason. Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic... Employees: 184.

Q: What are the risks of investing in HUMA?

Identify key risks of investing in HUMA — debt, competition, volatility, and sector headwinds.

Q: Is HUMA a good long-term investment?

Evaluate HUMA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does HUMA have?

Review HUMA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is HUMA stock safe?

🦉

Humacyte, Inc. (HUMA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOLaura E. Niklason

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology...

Key Executives

Name	Title
Dale A. Sander	Chief Financial Officer, Chief Corporate Development Officer & Treasurer
Heather Connelly	Executive Vice President Regulatory Affairs & Quality
Jim Mercadante	Chief Commercial Officer
Laura E. Niklason	Founder, President, Chief Executive Officer & Director
Lisa Molyneux	Executive Vice President of Enterprise Planning & Analysis
Rick McElheny	Senior Vice President of Business Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

HUMA Profile Financials

What are the risks of investing in HUMA? Is HUMA a good long-term investment? How much debt does HUMA have?